摘要
经RT-PCR扩增了SARS冠状病毒(SARS-CoV)BJ01株的PU5基因(putativeuncharacterizedgene5)的cDNA,将其克隆到原核表达载体pGEX-6P-1中,命名为pGEX-PU5,测序正确后将阳性质粒转化到大肠杆菌BL21(DE3)中,IPTG诱导表达,表达的融合蛋白命名为pGEX-PUP5,并用GlutathioneSwpharoseTM4B亲和层析柱对表达产物进行纯化,然后用PreScissionTMProtease酶对融合蛋白进行解离,获得PUP5蛋白,用抗SARS-CoV卵黄抗体IgY和GST-tag单克隆抗体分别对表达的目的蛋白做Westernblot鉴定,证明所表达的蛋白具有免疫学活性。本研究应用原核表达系统表达了PUP5蛋白,为进一步解析该蛋白功能奠定了基础。
The complementary DNA of putative uncharacterized gene 5 (PU5) was prepared fi'om SARS coronavirus (SARS-CoV) gene RNA by RT-PCR. The amplified fi'agment was cloned into the plasmid vector pGEX-6P-1. The recombinant vector was designated pGEX-PUS. The putative uncharacterized protein 5 (PUP5) of SARS-CoV was expressed in E. coli as fusion protein with GST protein at N-terminus. The recombinant protein was identified by Western blot. The soluble parts of the cell extract were then purified by Glutathione SwpharoseTM 4B and purified putative uncharacterized protein 5 was harvested by PreScissionTM Protease witch cleaved the purified protein.
出处
《中国预防兽医学报》
CAS
CSCD
北大核心
2006年第4期457-460,465,共5页
Chinese Journal of Preventive Veterinary Medicine